Biocardia, Inc. (BCDA) — 10-Q Filings
All 10-Q filings from Biocardia, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
BioCardia's Cash Boosted by Offerings Amidst Mounting Losses
— Nov 12, 2025 Risk: high
BioCardia, Inc. (BCDA) reported a net loss of $1.48 million for the three months ended September 30, 2025, an improvement from a net loss of $1.74 million in th -
BioCardia Reports Q1 2025 Results, Details April Financing
— May 14, 2025 Risk: medium
BioCardia, Inc. filed its Q1 2025 10-Q report on May 14, 2025, detailing its financial performance for the period ending March 31, 2025. The company has been in -
BioCardia Files Q3 2024 10-Q
— Nov 13, 2024 Risk: medium
BioCardia, Inc. filed its 10-Q for the period ending September 30, 2024, reporting on its financial performance. The company's financial statements for the nine -
BioCardia, Inc. Files Q2 2024 10-Q
— Aug 13, 2024 Risk: medium
BioCardia, Inc. filed its 10-Q for the period ending June 30, 2024, reporting on its financial performance and business activities. The company's fiscal year en -
BioCardia, Inc. Files 10-Q for Q1 2024
— May 14, 2024 Risk: medium
BioCardia, Inc. (BCDA) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. BioCardia, Inc. filed a 10-Q report for the period ending March 31, 2024. T
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX